The US has approved a high-dose version of Novo Nordisk's Wegovy, which has shown significant weight loss in clinical trials. This approval adds to the existing profile of Wegovy, which is already available in other forms. The exact details of the approval and its implications are not entirely clear, with some reports mentioning an injection and others referencing a pill.